Showing 2951-2960 of 7324 results for "".
Pay it Backwards
https://practicaldermatology.com/topics/practice-management/pay-it-backwards/20640/Why do women in dermatology earn only 83 percent of what men earn?The Future of Telemedicine in Aesthetics
https://practicaldermatology.com/topics/practice-management/the-future-of-telemedicine-in-aesthetics/21073/What are promises and pitfalls of remote medical consultation and care delivery in aesthetics?Beware the Redheaded Patient: Fact or Fiction in Cosmetic and Surgical Dermatology?
https://practicaldermatology.com/topics/general-topics/beware-the-redheaded-patient-fact-or-fiction-in-cosmetic-and-surgical-dermatology/21417/One of the winning presentations given by dermatology residents at the Cosmetic Surgery Forum in December 2013.Charles Crutchfield III, MD, FAAD
https://practicaldermatology.com/topics/practice-management/charles-crutchfield-iii-md-faad/21433/Tazarotene Lotion for Acne
https://practicaldermatology.com/topics/acne-rosacea/tazarotene-lotion-for-acne/23388/Tazarotene Lotion 0.045% offers dermatologists a new option that is effective and well tolerated for treating acne.Analyzing Safety Data From Level Up
https://practicaldermatology.com/series/the-practical-dermatology-podcast/analyzing-safety-data-from-level-up/33944/The latest news and updates, plus Matthew Zirwas, MD, FAAD, joins Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, to discuss the importance of the Week 16 safety data from the Level Up study on upadacitinib. Silverberg JI, Bunick CG, et al. Efficacy and safety of upadacitinib versuSquamoid Eccrine Ductal Carcinoma: A Diagnostic Challenge
https://practicaldermatology.com/youngmd-connect/resident-resource-center/squamoid-eccrine-ductal-carcinoma-a-diagnostic-challenge/23970/Squamoid eccrine ductal carcinoma is often initially misdiagnosed as squamous cell carcinoma.Physician Spotlight: Vishal Anil Patel, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-vishal-anil-patel-md/23899/Stoking the Embers: Re-exploring Topical Coal Products
https://practicaldermatology.com/columns/clinical-focus-1/stoking-the-embers-re-exploring-topical-coal-products/23825/A Closer Look at Cibinqo for AD Management
https://practicaldermatology.com/topics/atopic-dermatitis/a-closer-look-at-cibinqo-for-ad-management/23664/Oral JAK inhibitors offer rapid onset of efficacy and some flexibility in the management of moderate to severe eczema.